Electronic noses detect volatile organic compounds in exhaled breath to diagnose cancer
THURSDAY, June 30, 2022 (HealthDay News) — Electronic noses (e-noses) appear to have a relatively high diagnostic accuracy in the detection of cancer from exhaled breath, according to a systematic review and meta-analysis published online June 29 in JAMA Network Open.
Max H.M.C. Scheepers, M.D., from Maastricht University in the Netherlands, and colleagues conducted a systematic literature review to identify studies evaluating the diagnostic accuracy and methodologic challenges of using e-noses for the detection of cancer.
Based upon 52 included feasibility studies (3,677 patients with cancer), the researchers found that the sensitivity of e-noses ranged from 48.3 to 95.8 percent and the specificity from 10.0 to 100.0 percent. Pooled analysis yielded a mean area under the receiver operating characteristic curve of 94 percent, a sensitivity of 90 percent, and a specificity of 87 percent. Differences in the selection of patients, endogenous and exogenous factors, and collection of exhaled breath resulted in considerable heterogeneity of the studies.
“Although e-noses were found to have promising accuracy in detecting cancer, there is a need for standardized external validation studies that evaluate their diagnostic accuracy so that their role in the diagnostic workup of cancer can be established,” the authors write.
Alcohol-Attributable Cancer Mortality Has Increased Significantly in the U.S. 
Cancer Risk ID"d for Asian American, NHPI Population 
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer 
Machine Learning Model IDs Heart Failure With Reduced Ejection Fraction Using Routine Lab Indicators 
2011 to 2021 Saw Heart Failure-Related Hospitalization Rise in CKD 
Addition of CAC to PREVENT-ASCVD Equations May Improve Predictive Utility in Certain Patients 
Central Adiposity Reclassifies Cardiovascular Risk Across BMI Spectrum .jpg)
Warning Symptoms, Clinical History Can Predict Sudden Cardiac Arrest 
